ARTICLE | Clinical News
Omacor: Phase III started
December 21, 2009 8:00 AM UTC
Takeda began a double-blind, Japanese Phase III trial of TAK-085. Pronova granted Takeda exclusive Japanese rights to the program in 2005. The product is marketed as Omacor as an adjunct to diet to tr...